Cord blood transfusions for very premature babies
Part of Blood & lymphatic clinical trials.
This study tests whether using cord blood (the blood left in the umbilical cord after birth) that is rich in fetal hemoglobin (the type of hemoglobin babies have before birth) can make blood transfusions safer and more personalized for very premature babies. If this works, it might reduce the need for multiple transfusions and improve outcomes for preterm infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born very early, between 24 and 31 weeks of pregnancy.
- Your baby must need at least one red blood cell transfusion during their hospital stay.
- You must give written permission for your baby to join the study.
- Your baby cannot have already had a blood transfusion before joining.
- The pregnancy cannot have had certain severe complications, like hemolytic disease, fetal hydrops, or major birth defects.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether red blood cells made from donated cord blood are safe and effective for very premature babies who need a transfusion. It may offer an alternative to standard donor blood for these fragile infants.
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
This study looks at how red blood cell transfusions affect health problems in babies born before 32 weeks of pregnancy. It may help doctors understand if transfusions are linked to complications of prematurity.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This study looks at whether a specific “blood warming” approach can help very preterm babies keep their body temperature from getting too low (hypothermia). It’s intended to reduce temperature drops around the time they receive red blood cell transfusions.
Hear when a new Prematurity Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.